GT Healthcare Capital Partners overview
Stories about GT Healthcare Capital Partners
Ultromics raises about $13.4 mln from Oxford Sciences Innovation, Neptune, RT Ventures, GT Healthcare, others
Ultromics has raised about $13.4 million in Series-A investment led by Oxford Sciences Innovation and joined by Neptune, RT Ventures, GT Healthcare, Tanarra and Fushia. Individual investors Andre Crawford-Brunt and Dieter Spälti also participated.
GT Healthcare Capital Partners contact information
Offices
Contacts
| Name | Job title | Location | |
|---|---|---|---|
| Key Contact | Job titleVice President | LocationHong Kong, Hong Kong | Email |
Job titleVenture Partner | LocationHong Kong, Hong Kong | Email | |
Job titleInvestment Analyst | LocationShanghai, China | Email | |
Job titlePartner | LocationShanghai, China | Email | |
GT Healthcare Capital Partners funds managed
Closed funds: 1
| Fund | Fund size | Close date | Strategy |
|---|---|---|---|
Fund size | Close date- | Strategy | |
Stories that mention GT Healthcare Capital Partners
GI Windows Medical Corp lands $16.4m
West Bridgewater, Massachusetts-based GI Windows Medical Corp, a clinical-stage, privately-held medical device company, has raised $16.4 million in Series A-1 financing.
GI Windows Corp closes $14.6 mln Series A
West Bridgewater, Massachusetts-based GI Windows Corp, a medical device company, has raised $14.6 million in Series A financing.
Oxford Finance provides $60 mln to VC-backed RefleXion Medical
Oxford Finance LLC has provided a $60 million loan to Hayward, California-based RefleXion Medical Inc, a biotargeting oncology company. Armentum Partners served as financial adviser to RefleXion Medical on the financing. RefleXion is backed by TPG Growth/The Rise Fund, Sofinnova Partners, KCK Group, Venrock, T. Rowe Price Associates, Inc, GT Healthcare Capital Partners, Pfizer Venture Investments and Johnson & Johnson Innovation, JJDC Inc.
RefleXion Medical rakes in over $100 mln Series C
Hayward, California-based RefleXion Medical, a developer of biology-guided radiotherapy system for targeted cancer treatment, has raised more than $100 million in Series C funding. The Rise Fund, an impact investment fund managed by TPG Growth, led the round with participation from other investors that included T. Rowe Price Associates, Inc, GT Healthcare Capital Partners, Sofinnova Partners, KCK Group, Venrock, Pfizer Venture Investments and Johnson & Johnson Innovation – JJDC Inc.